Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Ravelli

Showing results (321-330 of 342) with videos related to

Pageof 35
Sort By:
Annals of the Rheumatic Diseases|February 12, 2016
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
Annals of the Rheumatic Diseases|April 15, 2010
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisationNicolino Ruperto, Seza Ozen, Angela Pistorio, et al.
Annals of the Rheumatic Diseases|February 15, 2025
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task forceVeronika Rypdal, Hermine I Brunner, Brian M Feldman, et al.
Pediatric Rheumatology Online Journal|December 21, 2016
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanerceptSara Verazza, Sergio Davì, Alessandro Consolaro, et al.
The Journal of Rheumatology|April 17, 2015
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisFrancesca Minoia, Sergio Davì, AnnaCarin Horne, et al.
Annals of the Rheumatic Diseases|May 23, 2025
Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task forceAngelo Ravelli, Silvia Rosina, Jayne M MacMahon, et al.
Autoimmunity Reviews|July 6, 2026
The landscape of serum autoantibodies in lupus nephritisMaurizio Bruschi, Federico Alberici, Gabriella Moroni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2014
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisSergio Davì, Francesca Minoia, Angela Pistorio, et al.
Autoimmunity Reviews|March 29, 2024
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidenceMaurizio Bruschi, Andrea Angeletti, Marco Prunotto, et al.
Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Pageof 35

Showing results (321-330 of 342) with videos related to

Sort By:
Pageof 35
Annals of the Rheumatic Diseases|February 12, 2016
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
Annals of the Rheumatic Diseases|April 15, 2010
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisationNicolino Ruperto, Seza Ozen, Angela Pistorio, et al.
Annals of the Rheumatic Diseases|February 15, 2025
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task forceVeronika Rypdal, Hermine I Brunner, Brian M Feldman, et al.
Pediatric Rheumatology Online Journal|December 21, 2016
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanerceptSara Verazza, Sergio Davì, Alessandro Consolaro, et al.
The Journal of Rheumatology|April 17, 2015
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisFrancesca Minoia, Sergio Davì, AnnaCarin Horne, et al.
Annals of the Rheumatic Diseases|May 23, 2025
Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task forceAngelo Ravelli, Silvia Rosina, Jayne M MacMahon, et al.
Autoimmunity Reviews|July 6, 2026
The landscape of serum autoantibodies in lupus nephritisMaurizio Bruschi, Federico Alberici, Gabriella Moroni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2014
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisSergio Davì, Francesca Minoia, Angela Pistorio, et al.
Autoimmunity Reviews|March 29, 2024
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidenceMaurizio Bruschi, Andrea Angeletti, Marco Prunotto, et al.
Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Pageof 35